Share on StockTwits

Relypsa (NASDAQ:RLYP) SVP Wilhelm Stahl unloaded 15,785 shares of Relypsa stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $25.29, for a total transaction of $399,202.65. Following the completion of the sale, the senior vice president now directly owns 5,500 shares of the company’s stock, valued at approximately $139,095. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Relypsa (NASDAQ:RLYP) traded down 3.46% on Wednesday, hitting $24.03. 178,786 shares of the company’s stock traded hands. Relypsa has a 1-year low of $11.55 and a 1-year high of $52.74. The stock has a 50-day moving average of $24.80 and a 200-day moving average of $27.56. The company’s market cap is $816.9 million.

Relypsa (NASDAQ:RLYP) last announced its earnings results on Monday, August 11th. The company reported ($0.51) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.57) by $0.06. On average, analysts predict that Relypsa will post $-2.47 earnings per share for the current fiscal year.

Separately, analysts at Stifel Nicolaus raised their price target on shares of Relypsa from $45.00 to $47.00 in a research note on Tuesday, August 12th. They now have a “buy” rating on the stock. Eight analysts have rated the stock with a buy rating, The company has a consensus rating of “Buy” and an average target price of $48.50.

Relypsa, Inc is a pharmaceutical company focused on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases.

Receive News & Ratings for Relypsa Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relypsa Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.